Similar articles

• [Morphologic study of iliac crest spongiosa in patients with osteoporosis treated with combination therapy of pulsatile administration of parathyroid hormone (1-38 hPTH) and sequential addition of calcitonin nasal spray].

  Vogel M, Hesch RD, Delling G. Vogel M, et al. Med Klin (Munich). 1990 Feb 15;85(2):82-6. Med Klin (Munich). 1990. PMID: 2319988 German.
• [Therapy of osteoporosis using the ADFR schedule (especially with parathyroid hormone and etidronate)].

  Ziegler R. Ziegler R. Internist (Berl). 1991 Feb;32(2):76-9. Internist (Berl). 1991. PMID: 1903362 Review. German. No abstract available.
• [The new concept of osteoporosis. Early diagnosis, prevention and therapy are possible today].

  Hesch RD, Harms H, Rittinghaus EF, Brabant G. Hesch RD, et al. Fortschr Med. 1990 Apr 15;108(11):219-21. Fortschr Med. 1990. PMID: 2358288 German.
• PTH: a future role in the management of osteoporosis?

  Reeve J. Reeve J. J Bone Miner Res. 1996 Apr;11(4):440-5. doi: 10.1002/jbmr.5650110404. J Bone Miner Res. 1996. PMID: 8992874 Review. No abstract available.
• [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].

  Agnusdei D, Gonnelli S, Camporeale A, Batignani T, Nardi P, Ianes A, Gennari C. Agnusdei D, et al. Minerva Endocrinol. 1989 Jul-Sep;14(3):169-76. Minerva Endocrinol. 1989. PMID: 2695815 Clinical Trial. Italian.